NCT03558607 2020-03-19
The Role of Ruxolitinib in Secondary Acute Myelogenous Leukemia Evolving From Myeloproliferative Neoplasm
Seoul National University Hospital
Phase 1/2 Unknown
Clinical Trials
1 trialsPhase 1/2 × Interventional × Secondary Acute Myelogenous Leukemia Evolving From Myeloproliferative Disorder × Clear all